Unknown

Dataset Information

0

VHL substrate transcription factor ZHX2 as an oncogenic driver in clear cell renal cell carcinoma.


ABSTRACT: Inactivation of the von Hippel-Lindau (VHL) E3 ubiquitin ligase protein is a hallmark of clear cell renal cell carcinoma (ccRCC). Identifying how pathways affected by VHL loss contribute to ccRCC remains challenging. We used a genome-wide in vitro expression strategy to identify proteins that bind VHL when hydroxylated. Zinc fingers and homeoboxes 2 (ZHX2) was found as a VHL target, and its hydroxylation allowed VHL to regulate its protein stability. Tumor cells from ccRCC patients with VHL loss-of-function mutations usually had increased abundance and nuclear localization of ZHX2. Functionally, depletion of ZHX2 inhibited VHL-deficient ccRCC cell growth in vitro and in vivo. Mechanistically, integrated chromatin immunoprecipitation sequencing and microarray analysis showed that ZHX2 promoted nuclear factor ?B activation. These studies reveal ZHX2 as a potential therapeutic target for ccRCC.

PROVIDER: S-EPMC6154478 | BioStudies |

REPOSITORIES: biostudies

Similar Datasets

2018-07-19 | GSE109953 | GEO
| S-EPMC7988700 | BioStudies
2022-07-27 | GSE186717 | GEO
| S-EPMC7206010 | BioStudies
| S-EPMC5481740 | BioStudies
| S-EPMC8470481 | BioStudies
| S-EPMC5350518 | BioStudies
| S-EPMC8548775 | BioStudies
| S-EPMC8295262 | BioStudies
| S-EPMC4246264 | BioStudies